25572 Impact of risankizumab on the duration of PASI90 achievement: A post hoc analysis of 4 phase III clinical trials

Saved in:

Bibliographic Details
Published in	Journal of the American Academy of Dermatology Vol. 85; no. 3; p. AB62
Main Authors	Lebwohl, Mark G., Soliman, Ahmed M., Yang, Hongbo, Wang, Jessie, Koenigsberg, Sarah H., Anderson, Annika, Padilla, Bryon, Pinter, Andreas
Format	Journal Article
Language	English
Published	Elsevier Inc 01.09.2021
Online Access	Get full text

Loading…

Be the first to leave a comment!